Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Valeant extends Allergan bid deadline to end of 2014

Valeant extends Allergan bid deadline to end of 2014 Valeant had initially given Botox makers Allergan a deadline of August 15, 2014, to make a decision on its $53bn offer, which was proposed in June.

Allergan sues Valeant and Pershing for insider trading

Allergan sues Valeant and Pershing for insider trading The Botox manufacturer filed suit in a Californian court claiming Valeant's hedge fund backer Pershing Square Capital - and its owner Bill Ackman - had fraudulently built up a stake in the ... Last month the Botox manufacturer announced plans to cut 1,

SMC decides Celgene's Imnovid is not cost-effective

SMC decides Celgene's Imnovid is not cost-effective There was also a positive decision on Allergan's Botox (botulinum toxin type A) for use in the management of bladder dysfunctions.

Pershing mounts assault on Allergan board

Pershing mounts assault on Allergan board Specialty pharmaceutical company Allergan - best known as the manufacturer of cosmetic medicine Botox (onabotulinumtoxinA) - has rebuffed Valeant's advances and repeatedly argued that the acquisitive Canadian company is an empire built

2014: a year to build pharma's reputation

2014: a year to build pharma's reputation become a major player with a bid for Allergan, despite solid resistance from the company behind Botox.

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics